Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.86M Sell
203,371
-7,716
-4% -$172K ﹤0.01% 1533
2026
Q1
$3.58M Buy
211,087
+19,285
+10% +$413K ﹤0.01% 1742
2025
Q4
$4.93M Sell
191,802
-43,691
-19% -$1M ﹤0.01% 1473
2025
Q3
$5.07M Sell
235,493
-59,041
-20% -$1.34M ﹤0.01% 1361
2025
Q2
$6.48M Buy
294,534
+42,502
+17% +$932K ﹤0.01% 1579
2025
Q1
$5.63M Buy
252,032
+14,297
+6% +$308K ﹤0.01% 1510
2024
Q4
$4.1M Sell
237,735
-17,102
-7% -$265K ﹤0.01% 1709
2024
Q3
$4.27M Sell
254,837
-10,945
-4% -$263K ﹤0.01% 1655
2024
Q2
$7.6M Buy
265,782
+172,645
+185% +$5.2M ﹤0.01% 1263
2024
Q1
$3.55M Sell
93,137
-4
-0% -$151 ﹤0.01% 1410
2023
Q4
$3.46M Buy
93,141
+16,355
+21% +$549K ﹤0.01% 1430
2023
Q3
$2.61M Buy
76,786
+9,513
+14% +$359K ﹤0.01% 1490
2023
Q2
$2.16M Hold
67,273
﹤0.01% 1610
2023
Q1
$2.16M Buy
+67,273
New +$2.22M ﹤0.01% 1610
2022
Q4
Sell
-59,127
Closed -$2.19M 2701
2022
Q3
$2.19M Sell
59,127
-13,792
-19% -$516K ﹤0.01% 1553
2022
Q2
$2.12M Buy
72,919
+2,880
+4% +$103K ﹤0.01% 1594
2022
Q1
$3.6M Buy
70,039
+7,995
+13% +$342K ﹤0.01% 1498
2021
Q4
$3.12M Sell
62,044
-24,866
-29% -$1.39M ﹤0.01% 1649
2021
Q3
$4.87M Buy
86,910
+32,725
+60% +$1.81M ﹤0.01% 1359
2021
Q2
$3.2M Buy
54,185
+27,886
+106% +$1.57M ﹤0.01% 1626
2021
Q1
$1.17M Hold
26,299
﹤0.01% 2014
2020
Q4
$1.11M Buy
26,299
+15,699
+148% +$511K ﹤0.01% 1934
2020
Q3
$312K Buy
+10,600
New +$292K ﹤0.01% 2291

Other funds holding PGNY

UBS AM's PGNY Position: Q2 2026 in Review

UBS AM reduced its Progyny (PGNY) stake by 3.7% in Q2 2026, selling an estimated $172K and leaving 203,371 shares worth $5.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1533.

UBS AM first reported a position in PGNY in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.6M in Q2 2024. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • UBS AM held 203,371 shares of Progyny worth $5.86M as of Q2 2026.
  • UBS AM sold 7,716 Progyny shares in Q2 2026, an estimated $172K.
  • Progyny made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1533 holding.
  • UBS AM first reported a position in Progyny in Q3 2020 and has held it in 23 quarters since.
  • UBS AM's Progyny position peaked at $7.6M in Q2 2024.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.